John Matthew Maris, M.D.
Professor of Pediatrics
Department: Pediatrics
Graduate Group Affiliations
Contact information
The Children's Hospital of Philadelphia
Division of Oncology
Colket Translational Research Building
3501 Civic Center Boulevard #3060
4399
Philadelphia, PA 19104-4318
Division of Oncology
Colket Translational Research Building
3501 Civic Center Boulevard #3060
4399
Philadelphia, PA 19104-4318
Office: 215 590 5244
Fax: 267 426 0685
Fax: 267 426 0685
Email:
MARIS@CHOP.EDU
MARIS@CHOP.EDU
Publications
Links
Search PubMed for articles
Abramson Family Cancer Research Institute webpage.
Maris Lab Website
Search PubMed for articles
Abramson Family Cancer Research Institute webpage.
Maris Lab Website
Education:
B.S. (Biology)
Wheeling College , 1983.
M.D. (Medicine)
University of Pennsylvania, 1989.
Permanent linkB.S. (Biology)
Wheeling College , 1983.
M.D. (Medicine)
University of Pennsylvania, 1989.
Selected Publications
Quach Alekist, Ji Lingyun, Mishra Vikash, Sznewajs Aimee, Veatch Janet, Huberty John, Franc Benjamin, Sposto Richard, Groshen Susan, Wei Denice, Fitzgerald Paul, Maris John M, Yanik Gregory, Hawkins Randall A, Villablanca Judith G, Matthay Katherine K: Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma. Pediatric blood & cancer 56(2): 191-201, Feb 2011.Wang Kai, Diskin Sharon J, Zhang Haitao, Attiyeh Edward F, Winter Cynthia, Hou Cuiping, Schnepp Robert W, Diamond Maura, Bosse Kristopher, Mayes Patrick A, Glessner Joseph, Kim Cecilia, Frackelton Edward, Garris Maria, Wang Qun, Glaberson Wendy, Chiavacci Rosetta, Nguyen Le, Jagannathan Jayanti, Saeki Norihisa, Sasaki Hiroki, Grant Struan F A, Iolascon Achille, Mosse Yael P, Cole Kristina A, Li Hongzhe, Devoto Marcella, McGrady Patrick W, London Wendy B, Capasso Mario, Rahman Nazneen, Hakonarson Hakon, Maris John M: Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 469(7329): 216-20, Jan 2011.
Bagatell Rochelle, London Wendy B, Wagner Lars M, Voss Stephan D, Stewart Clinton F, Maris John M, Kretschmar Cynthia, Cohn Susan L: Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29(2): 208-13, Jan 2011.
Keir Stephen T, Maris John M, Lock Richard, Kolb E Anders, Gorlick Richard, Carol Hernan, Morton Christopher L, Reynolds C Patrick, Kang Min H, Watkins Amy, Houghton Peter J, Smith Malcolm A: Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing program. Pediatric blood & cancer 55(6): 1126-33, Dec 2010.
Delgado David C, Hank Jacquelyn A, Kolesar Jill, Lorentzen David, Gan Jacek, Seo Songwon, Kim Kyungmann, Shusterman Suzanne, Gillies Stephen D, Reisfeld Ralph A, Yang Richard, Gadbaw Brian, DeSantes Kenneth B, London Wendy B, Seeger Robert C, Maris John M, Sondel Paul M: Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy. Cancer research 70(23): 9554-61, Dec 2010.
Qing Guoliang, Skuli Nicolas, Mayes Patrick A, Pawel Bruce, Martinez Daniel, Maris John M, Simon M Celeste: Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. Cancer research 70(24): 10351-61, Dec 2010.
Shusterman Suzanne, London Wendy B, Gillies Stephen D, Hank Jacquelyn A, Voss Stephan D, Seeger Robert C, Reynolds C Patrick, Kimball Jennifer, Albertini Mark R, Wagner Barrett, Gan Jacek, Eickhoff Jens, DeSantes Kenneth B, Cohn Susan L, Hecht Toby, Gadbaw Brian, Reisfeld Ralph A, Maris John M, Sondel Paul M: Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 28(33): 4969-75, Nov 2010.
Kolb E Anders, Gorlick Richard, Houghton Peter J, Morton Christopher L, Neale Geoffrey, Keir Stephen T, Carol Hernan, Lock Richard, Phelps Doris, Kang Min H, Reynolds C Patrick, Maris John M, Billups Catherine, Smith Malcolm A: Initial testing (stage 1) of AZD6244 (ARRY-142886) by the Pediatric Preclinical Testing Program. Pediatric blood & cancer 55(4): 668-77, Oct 2010.
Yu Alice L, Gilman Andrew L, Ozkaynak M Fevzi, London Wendy B, Kreissman Susan G, Chen Helen X, Smith Malcolm, Anderson Barry, Villablanca Judith G, Matthay Katherine K, Shimada Hiro, Grupp Stephan A, Seeger Robert, Reynolds C Patrick, Buxton Allen, Reisfeld Ralph A, Gillies Steven D, Cohn Susan L, Maris John M, Sondel Paul M, : Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. The New England journal of medicine 363(14): 1324-34, Sep 2010.
Baker David L, Schmidt Mary L, Cohn Susan L, Maris John M, London Wendy B, Buxton Allen, Stram Daniel, Castleberry Robert P, Shimada Hiroyuki, Sandler Anthony, Shamberger Robert C, Look A Thomas, Reynolds C Patrick, Seeger Robert C, Matthay Katherine K, : Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. The New England journal of medicine 363(14): 1313-23, Sep 2010.